Victory Capital Management Inc Tg Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 32,679 shares of TGTX stock, worth $965,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,679

Previous 26,212 24.67%

Holding current value

$965,337

Previous $466,000 63.95%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$17.21 - $25.28 $111,297 - $163,485	6,467 Added 24.67%	32,679 $764,000
Q2 2024 Aug 05, 2024	BUY	$13.32 - $19.19 $68,851 - $99,193	5,169 Added 24.56%	26,212 $466,000
Q1 2024 May 03, 2024	BUY	$13.02 - $21.3 $32,823 - $53,697	2,521 Added 13.61%	21,043 $320,000
Q4 2023 Feb 05, 2024	BUY	$6.68 - $18.81 $22,872 - $64,405	3,424 Added 22.68%	18,522 $316,000
Q3 2023 Nov 06, 2023	SELL	$8.36 - $26.5 $5.75 Million - $18.2 Million	-688,267 Reduced 97.85%	15,098 $126,000
Q2 2023 Jul 27, 2023	BUY	$15.48 - $35.0 $10.7 Million - $24.1 Million	688,219 Added 4543.9%	703,365 $17.5 Million
Q1 2023 May 02, 2023	SELL	$10.23 - $19.34 $225 - $425	-22 Reduced 0.15%	15,146 $227,000
Q4 2022 Feb 10, 2023	BUY	$5.01 - $11.83 $681 - $1,608	136 Added 0.9%	15,168 $179,000
Q4 2022 Feb 09, 2023	SELL	$5.01 - $11.83 $137,279 - $324,153	-27,401 Reduced 64.57%	15,032 $177,000
Q3 2022 Nov 02, 2022	BUY	$4.57 - $8.4 $69,345 - $127,461	15,174 Added 55.67%	42,433 $251,000
Q4 2021 Feb 07, 2022	SELL	$15.2 - $35.51 $5.74 Million - $13.4 Million	-377,757 Reduced 93.27%	27,259 $518,000
Q3 2021 Nov 02, 2021	SELL	$21.78 - $40.45 $447,513 - $831,126	-20,547 Reduced 4.83%	405,016 $13.5 Million
Q2 2021 Aug 03, 2021	SELL	$32.5 - $48.96 $683,280 - $1.03 Million	-21,024 Reduced 4.71%	425,563 $16.5 Million
Q1 2021 May 04, 2021	BUY	$41.61 - $54.3 $7.36 Million - $9.61 Million	176,915 Added 65.6%	446,587 $21.5 Million
Q4 2020 Feb 01, 2021	BUY	$25.27 - $54.9 $5.86 Million - $12.7 Million	232,074 Added 617.25%	269,672 $14 Million
Q3 2020 Nov 09, 2020	SELL	$18.49 - $27.24 $296,283 - $436,493	-16,024 Reduced 29.88%	37,598 $1.01 Million
Q1 2020 May 04, 2020	SELL	$7.14 - $15.99 $21,398 - $47,922	-2,997 Reduced 5.29%	53,622 $528,000
Q4 2019 Feb 06, 2020	BUY	$5.1 - $11.2 $15,284 - $33,566	2,997 Added 5.59%	56,619 $628,000
Q4 2019 Feb 04, 2020	SELL	$5.1 - $11.2 $15,284 - $33,566	-2,997 Reduced 5.29%	53,622 $762,000
Q3 2019 Nov 12, 2019	BUY	$5.38 - $8.99 $293,210 - $489,955	54,500 Added 2571.97%	56,619 $318,000
Q3 2018 Nov 01, 2018	BUY	$5.15 - $14.0 $1,431 - $3,892	278 Added 15.1%	2,119 $12,000
Q1 2018 May 04, 2018	SELL	$8.7 - $16.8 $10,570 - $20,412	-1,215 Reduced 39.76%	1,841 $26,000
Q2 2017 Aug 07, 2017	BUY	N/A	3,056	3,056 $31,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Tg Therapeutics, Inc. Transaction History